Get started

Oversold

Overbought overreaction: short BYND 138c June 14BYND reported earnings with a wider loss in the first quarter of 2019 due to higher costs and expenses, but outstanding guidance for next year. Even bullish analysts have set price targets below the current market price of $135. JPMorgan is overweight with a $120 price target, Bernstein rates outperform with a $107 price target, Credit Suisse sets a price target of $125, Goldman set a target of $76 and BoA Merrill Lynch sets a price target of $101. Competition is also increasing in the already-crowded space. Nestle announced earlier this week that they will launch a plant-based burger, dubbed "the Awesome Burger." Burger King in in the process of adding the Impossible Foods burger nationwide and Tyson Foods is creating a plant-based protein that is mirrors Beyond's offerings. Beyond Meat is only one brand in a very competitive space. This huge jump of over 35% after reporting more losses, yet a "positive outlook" despite increasing vehement competition is an overreaction. The RSI indicators show a reading of a whopping 81, indicating that BYND stock is extremely overbought. BYND is also trading outside of the bollingers, making it fit for mean reversion. The MACD indicator also shows that the momentum is waning. The Parabolic Stop and Reverse indicator is now above the candles, indicating a bearish movement to come. We are thus shorting the 138 calls with June 14th expiry (next Friday). This benefits from the expensive contract prices because of high implied volatility, and the near-term expiry thus allows us to collect theta premium.
NASDAQ:BYNDShort
by LaurenTrading
HOTH delivers +13% in profits so far & could jump past $8 today!===================== HOTH (Hoth Therapeutics, Inc.) Float: 3.86M Current Price: $6.80 Low: $6.75 High: $7.90 Realistic Gains/Loss: +13.18% Target Price: $10.00 Chart Analysis Investor Presentation Website | Recent News ======================== Members, Yesterday's low-float Nasdaq listed alert HOTH (Hoth Therapeutics, Inc.) started the day off hot, delivering up +13.18% in realistic profit. It then appeared that some profit taking took place, and shares pulled back to their day low of $6.70. HOTH appeared to form a base at those levels and bounced back in the afternoon, nearly closing in the green on heavy volume. We are banking that this afternoon's momentum will continue on into tomorrow's session. Especially considering the fact that we don't believe the Street got the full effect of yesterday's news release. This morning HOTH dropped huge news regarding its positive steps towards getting FDA approval for their game changing treatment for eczema, BioFlexa. Hoth Therapeutics Forms Wholly Owned Australian Subsidiary, in Preparation of Upcoming Clinical Trials for Atopic Dermatitis Solution NEW YORK, June 6, 2019 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis-also known as eczema-as well as dermatological and chronic wound disorders, today announced the formation of its subsidiary, Hoth Therapeutics Australia Pty Ltd, in anticipation to perform clinical trials for atopic dermatitis. Hoth Therapeutics Australia Pty Ltd will oversee the preparation and execution of Hoth's first clinical trial, known as Efficacy and Safety of BioLexa for the Treatment of Mild-to-Moderate Atopic Dermatitis. The newly formed entity will also be eligible for a significant Research and Development tax rebate. The subsidiary will supervise data management, biostatistical, medical monitoring, quality insurance, regulatory and central laboratory services to support the trial. "We are excited by the opportunity to work with Australian researchers and members of the international pharmaceutical industry, in regards to the development of our proprietary atopic dermatitis treatment," stated Mr. Robb Knie, CEO of Hoth Therapeutics. "This endeavor is a significant milestone for us, as we move towards clinical trials. Hoth is committed to working diligently with physicians, and regulators in order to successfully pilot our BioLexa Platform to the millions of people that are afflicted with atopic dermatitis." The subsidiary was formed in connection with Novotech and CoSec Consulting. Headquartered in Australia since 1996 and operating in the Asia Pacific region, Novotech is internationally recognized in the industry as a leading regional full-service contract research organization. Cosec Consulting provides carefully crafted compliance, governance and financial solutions for offshore companies undertaking research and development activities in Australia. This market friendly news sent shares soaring this morning, but we can only imagine the type of move it will make once it has more eyes on it. We also noticed that the Level II on this low-float biotech play is extremely thin, and we are anticipating a possible move past $8.00 when all is said and done. We witnessed some wild swings between $6 and $7 yesterday, with a little more volume HOTH could easily run past $8. Remember... HOTH is the perfect candidate for a monster breakout. The Company: Has a tight float of 3.86M Operates in the highly volatile biotech sector. (These Stocks Tend to Move Big On News) Is listed on the Nasdaq Exchange (High Liquidity) Has a $10 Price Target (+52% Upside) HOTH has been on our radar for quite some time now. After IPO'ing at $5.50, HOTH went on a tear, hitting a 52-week high of $13.88. HOTH's recent pullback has created the ultimate buy the dip opportunity for traders. We all know how explosive these small-cap biotech stocks can be... Any type of market friendly news could trigger a huge move in share price. On Wednesday we watched RWLK jump over +200% on positive FDA news. With HOTH's tiny 3.2M float, any type of market friendly news could send shares soaring. HOTH also has several bullish catalysts on the horizon that have us confident that its $10 price-target is well within reach. Atopic Dermatitis is a large and growing market Affects more than 32 million patients in the US 10 20% of all pediatric patients suffer from Atopic Dermatitis Need for new, differentiated therapies HOTH's BioLexa Platform offers a non corticosteroid approach to inhibit the formation of biofilms, which increases effectiveness of BioLexa in clearing current symptoms and preventing future flare ups Phase 2 study is currently being designed by renowned doctors and scientists and on track to start enrollment in Australia by end of 2019 Study will test efficacy, safety, and ease of use On target to complete Phase 2 clinical trial by end of Q1 2020 As you can see, HOTH is operating in an in-demand market and has several promising products in its pipeline. Can you imagine how high HOTH shares could go if it were to receive FDA approval? Based on our research, HOTH appears to be well on its way to becoming our next bio-tech alert to breakout for monster gains. The Bottom-Line We love these low-float bio-tech alerts. They have the tendency to breakout faster and bigger than any other sector. This is the only ticker that should be on your radar today. (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Click here to view our full profile on HOTH. Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twenty thousand dollars by Source 4 Communications LLC to conduct a two-day investor relations advertising and marketing campaign for HOTH. . Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
NASDAQ:HOTHLong
by RedHotStocks
1
Add ANFI to the top of your watchlist. SIgns $6M Contract + ===================== ANFI (Amira Nature Foods Ltd.) Float: 25.82M Alert Price: $1.05 Target Price: $6.00 Chart Analysis Investor Presentation Investor Webcast Website | Recent News ======================== Members, Our biggest NYSE-listed winner of 2019 looks ready to breakout big once again! It's time to add ANFI (Amira Nature Foods Ltd.) back to the top of your watchlist. After pulling back substantially from its 52-week high, ANFI appears to have found its bottom. The Company has recently made some market friendly announcements that we believe will serve as huge catalysts for an epic chart reversal. Announced the hiring of Brian M. Speck as Chief Financial Officer. With his many years of U.S. public company accounting experience Mr. Speck will assist ANFI in Westernizing their finance department as they focus on the international growth of their brands. Entered into contracts, which consist of approximately $9 million in revenue, to supply rice and institutional products to new customers in the Europe, Middle East, and Africa (“EMEA”) and Asia regions. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020. “We are extremely pleased to announce this order, which along with our previously announced customer order of $42M, amounts to over $51M. This equates to securing 26% of our forecasted $200M of FY2020 revenue just 52 days (14%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman. ANFI's recent strategic moves have us extremely bullish on this past triple-digit winner. In fact, we've done our very own chart analysis and see the potential for a move of over +153% in the very near future! If you've been following our recent alerts, you should know that our price targets have been pretty much right on the money. But that price target is quite modest compared to what Wall Street analysts are betting on. Top 10 Wealth Firm Puts $6.00 Price Target on a $1.00 Stock Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6. That's an upside of +471% from today's alert price! If you go to Google and search for the "Top 10 Wealth Firms" you'll notice that " Jefferies Wealth Management" is in the top 10 in the country. If that wasn't enough to have you sold on ANFI, you'll be happy to know that Jefferies isn't the only equity research firm that is bullish on ANFI... Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies recently initiated coverage on ANFI, and slapped on a $4.00 price target! That's well over +280% in upside potential from today's alert price. Their full research report is available here. To say that ANFI is undervalued at its current share price would be the understatement of the year. Here are a few other reasons why we have an extremely bullish outlook ANFI: Low float of just 25.82M Listed on the NYSE (High Liquidity) Products now available on Amazon in the United Kingdom. The Company is initially offering its Brown Basmati Rice 2kg product and is looking forward to adding more products. Reiterated its $200 million revenue guidance for the 2020 fiscal year ending March 31, 2020. Going forward, the Company’s focus will be on strengthening its international business and as such the 2020 fiscal year $200 million revenue guidance consists solely of international revenue (ex-India). Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6. Trading well below its average analyst price target of $6.00 (+471% Upside) Its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020. It's Indian subsidiary, Amira Foods India (“Amira India”), has converted Amira India debt into ordinary shares of Amira India. As a result of the debt conversion, the Company’s ownership in Amira India decreased from 80.4% to 49.8%. This event is a continuation of Amira’s focus on strengthening the Company’s international business. It is our opinion that ANFI is shaping up to be one of the top growth/value plays listed on the NYSE at the moment. As such, we ask that all members start their research on ANFI immediately, and consider building a position this morning at 9:30AM EST About Amira Nature Foods Founded in 1915, Amira has evolved into a global provider of packaged Indian specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under their flagship Amira brand as well as under other third party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira’s headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States. Company Highlights: Large Staple Consumer Category with Highly Supportive Industry and Sub Category Fundamentals A Market Lead with Differentiated Business Model Globally Diversified with Wide Customer Base and Broad Product Portfolio Vertically Integrated "State-of-the-art" Supply Chain and Operations Strong Financial Track Record, Underpinned by Stable Margins Highly Experienced and Successful Management Team Announced that its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020. Since its founding in 1915, Amira has evolved from a domestic, family owned Indian business to a professionally managed, global branded, publicly traded, growing packaged food company. Not only is the stock potentially undervalued based on its revenues and earnings, ANFI is also trading well below its book value, with a price-to-book ratio of 0.10, while the industry average is 1.81. With ANFI trading well below the industry average for some key valuation ratios, it could be a value play, and could even attract potential buyers. Moreover, Amira was able to increase at a compound annual growth rate of 15.5% between 2010 and 2017. With such high revenue growth rates, this company could be significantly undervalued by the market. According to Finviz, over 50% of the company is owned by insiders. That in mind, that shows that the company’s officers, directors, and key insiders are confident in the company. The Company has received numerous accolades: Since 2010, Amira has been recognized in multiple years by the World Economic Forum as a “Global Growth Company”, an invitation-only community consisting of ~300 of the world’s fastest-growing corporations The World Consulting & Research Corporation named Amira one of “Asia’s Most Promising Brands” Planman Marcom voted Amira the “INDIAN POWERBRAND” in the Food Category in 2011 and 2013 Amir was voted best partner in the “Staples” category in 2013 at the Bharti Walmart Private Limited Annual Supplier Conference VWP World Brand recognized the Amira Brand as “The Admired Brand of India” in 2014–2015 Inc. India featured Amira as one of India’s fastest growing mid-sized companies in 2010, 2011, 2012 and 2013 Product Portfolio Approximately three quarters of sales come from Basmati rice, the core focus of the company; Sells more than 20 owned brands globally, spanning numerous price points; Amira in India Amira has established 15 Company managed distribution centers in India to provide it greater control over its expansion efforts in its home country location. Amira is one of a handful of large relevant players in the domestic India market. Amira represents a meaningful opportunity to consolidate the market over time. Business Is Growing, Strategic Moves Will Expedite Growth Amira Foods is no startup. The international business is healthy and generated roughly $270 million in sales in 2018. Those numbers are coupled with respectable margins that rested at 14.3% of gross sales. However, the company expects to do better with the expectation to add an additional 100bp to the international margins. Notably, there will some be shrinkage to the margins, which may be adjusted lower to account for the separation of the Indian business, due to less vertical integration and less sourcing from the primary processor. However, even with the expected reductions in the margin and certain efficiencies, analysts are pointing to ANFI being able to maintain separate sales of roughly $200 million, albeit with a lower margin of approximately 650bp. However, even with the expected short-term declines, the assumption of the lesser $200 million in sales coupled with an EBITDA margin of an expected 8.8%, can imply that ANFI will generate a positive EBITDA run of roughly $17 million. And, that is a healthy number to build upon. Source: seekingalpha.com Recent Developments Appointment of Thomas Dennhardt (formerly Lidl) to CEO of Amira Basmati Rice GmbH (German subsidiary) Board appointment of Hervé Larren (formerly LVMH), bringing experience in building brands internationally EUR25mn Debt raise at 8.5% interest rate (due December 2023) Reduced ownership of India subsidiary to 49.8% Regains Compliance with NYSE Listing Requirements Latest News Amira Nature Foods Ltd Hires Brian M. Speck as Chief Financial Officer Amira Nature Foods Ltd (the "Company") (ANFI), a global provider of packaged specialty rice, today announced the hiring of Brian M. Speck as Chief Financial Officer. The Company continues to focus on the international growth of its brands and as such, continues to take steps to Westernize its corporate finance and executive team. Karan A. Chanana, Amira’s Chairman, commented, “Brian Speck is an excellent addition to our team, bringing his extensive financial and consumer industry background to the Company. We believe his many years of U.S. public company accounting experience will assist Amira in Westernizing our finance department as we focus on the international growth of our brands.” “I am excited to join the Company at a pivotal time in its history and helping it realize its international growth strategy,” Mr. Speck said. “After spending nearly two decades in various accounting roles, I look forward to bringing my experience to assist Amira’s efforts to grow its brands outside of India.” Since March 2018, Mr. Speck has been the Chief Financial Officer of Surge Holdings, Inc., a provider of a suite of financial and telecommunications services which are primarily marketed through small retail establishments which are utilized by members of its target market. Since October 2013, Mr. Speck has also been Director of Financial Reporting for Brio Financial Group, which the Company recently announced would be assisting the Company in its ongoing financial reporting. In his capacity at Brio, Mr. Speck consults various private and public companies in financial reporting, internal control development and evaluation, budgeting and forecasting. Prior to joining Brio, from 2011 to 2013, he was an audit supervisor at Wiss & Company. In that capacity, he was involved in the firm’s accounting and tax practice with industry focuses in manufacturing, wholesalers, construction contractors and professional service firms. Mr. Speck received a Master of Science in Accounting from Kean University. Market Outlook: Amira operates in the global packaged rice market and is a leading provider of Basmati rice, a long-grain aromatic rice with favorable health attributes that can be grown only in specific regions of the Indian sub-continent and part of the Punjab region located in Pakistan. The global rice market is an enormous market with stable growth, while specialty rice and specifically Basmati rice benefits from premium pricing and increasing consumption patterns. Demand for Basmati rice has remained strong over the past 10 years due to the increased consumption trends both in India and internationally. Leading players such as McCormick & Co., Hain Celestial, Rice 'n Spice, LT Foods, East End Foods, and Amira Nature Foods serve local as well as global consumers, which is reflected in the growth of Basmati rice market. The size of worldwide Basmati rice market was approximately $10.51 Billion in 2017 and is estimated to be worth $17.74 Billion by the end of 2022, with a robust CAGR of 11% between 2017 and 2022, according to Transparency Market Research (TMR). Rice is a $275bn Global Staple Category with Favorable Market Conditions Rice is the primary staple for >50% of the world’s population and provides > 20% of the global caloric intake Represents 30% of caloric consumption in Asia(4) Defensive and non-cyclical with steady growth Improves with age and has an extremely long shelf life (up to 5+ years) if stored properly Global rice consumption is growing, estimated to reach c.483 million metric tonnes in 2017(5) The global rice market is estimated at $275B and has grown at 2% volume CAGR over the 2010 – 2015 period Technical Analysis As we stated above, we've done our very own chart analysis and see the potential for a move of over +153% from here! We see a positive reversal from long-term support right here, and a positive cross looks imminent. The float of ANFI is extremely low for a NYSE listed company at just 25.82M. We know this ticker can make big moves on volume, so we wouldn't be too surprised if this ticker starts to breakout early. With its bullish $6.00 price target, we believe its upside potential far outweighs any downside risk. The Bottom Line ANFI has proven its ability run-up big in both the short and long-term. ANFI has the potential to be the biggest gainer on the NYSE, and deserves to be on the top of your watchlist. That being said, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The PennyStock101 Team Don't Miss Our Next Huge Winner... Text 'PS101' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI. We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI on three separate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
A
by DEXWireNews
2
Add $ANFI to the top of your watchlist. SIgns $6M Contract + ===================== ANFI (Amira Nature Foods Ltd.) Float: 25.82M Alert Price: $1.05 Target Price: $6.00 Chart Analysis Investor Presentation Investor Webcast Website | Recent News ======================== Members, Our biggest NYSE-listed winner of 2019 looks ready to breakout big once again! It's time to add ANFI (Amira Nature Foods Ltd.) back to the top of your watchlist. After pulling back substantially from its 52-week high, ANFI appears to have found its bottom. The Company has recently made some market friendly announcements that we believe will serve as huge catalysts for an epic chart reversal. Announced the hiring of Brian M. Speck as Chief Financial Officer. With his many years of U.S. public company accounting experience Mr. Speck will assist ANFI in Westernizing their finance department as they focus on the international growth of their brands. Entered into contracts, which consist of approximately $9 million in revenue, to supply rice and institutional products to new customers in the Europe, Middle East, and Africa (“EMEA”) and Asia regions. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020. “We are extremely pleased to announce this order, which along with our previously announced customer order of $42M, amounts to over $51M. This equates to securing 26% of our forecasted $200M of FY2020 revenue just 52 days (14%) into the fiscal year”, stated Karan A. Chanana, Amira’s Chairman. ANFI's recent strategic moves have us extremely bullish on this past triple-digit winner. In fact, we've done our very own chart analysis and see the potential for a move of over +153% in the very near future! If you've been following our recent alerts, you should know that our price targets have been pretty much right on the money. But that price target is quite modest compared to what Wall Street analysts are betting on. Top 10 Wealth Firm Puts $6.00 Price Target on a $1.00 Stock Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6. That's an upside of +471% from today's alert price! If you go to Google and search for the "Top 10 Wealth Firms" you'll notice that " Jefferies Wealth Management" is in the top 10 in the country. If that wasn't enough to have you sold on ANFI, you'll be happy to know that Jefferies isn't the only equity research firm that is bullish on ANFI... Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies recently initiated coverage on ANFI, and slapped on a $4.00 price target! That's well over +280% in upside potential from today's alert price. Their full research report is available here. To say that ANFI is undervalued at its current share price would be the understatement of the year. Here are a few other reasons why we have an extremely bullish outlook ANFI: Low float of just 25.82M Listed on the NYSE (High Liquidity) Products now available on Amazon in the United Kingdom. The Company is initially offering its Brown Basmati Rice 2kg product and is looking forward to adding more products. Reiterated its $200 million revenue guidance for the 2020 fiscal year ending March 31, 2020. Going forward, the Company’s focus will be on strengthening its international business and as such the 2020 fiscal year $200 million revenue guidance consists solely of international revenue (ex-India). Jefferies analyst Akshay Jagdale recently maintained his Buy rating on ANFI and set a price target of $6. Trading well below its average analyst price target of $6.00 (+471% Upside) Its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020. It's Indian subsidiary, Amira Foods India (“Amira India”), has converted Amira India debt into ordinary shares of Amira India. As a result of the debt conversion, the Company’s ownership in Amira India decreased from 80.4% to 49.8%. This event is a continuation of Amira’s focus on strengthening the Company’s international business. It is our opinion that ANFI is shaping up to be one of the top growth/value plays listed on the NYSE at the moment. As such, we ask that all members start their research on ANFI immediately, and consider building a position this morning at 9:30AM EST About Amira Nature Foods Founded in 1915, Amira has evolved into a global provider of packaged Indian specialty rice, with sales in over 40 countries today. Amira sells Basmati rice, premium long-grain rice grown only in certain regions of the Indian sub-continent, under their flagship Amira brand as well as under other third party brands. Amira sells its products primarily in emerging markets through a broad distribution network. Amira’s headquarters are in Dubai, United Arab Emirates, and it also has offices in India, Germany, the United Kingdom, and the United States. Company Highlights: Large Staple Consumer Category with Highly Supportive Industry and Sub Category Fundamentals A Market Lead with Differentiated Business Model Globally Diversified with Wide Customer Base and Broad Product Portfolio Vertically Integrated "State-of-the-art" Supply Chain and Operations Strong Financial Track Record, Underpinned by Stable Margins Highly Experienced and Successful Management Team Announced that its previously announced $30 million contract to supply third party branded basmati rice to a repeat customer in the Europe, Middle East, and Africa (“EMEA”) region was increased to $42 million within the provisions of the contract. The Company expects to recognize the benefit of this contract in the 2020 fiscal year ending March 31, 2020. Since its founding in 1915, Amira has evolved from a domestic, family owned Indian business to a professionally managed, global branded, publicly traded, growing packaged food company. Not only is the stock potentially undervalued based on its revenues and earnings, ANFI is also trading well below its book value, with a price-to-book ratio of 0.10, while the industry average is 1.81. With ANFI trading well below the industry average for some key valuation ratios, it could be a value play, and could even attract potential buyers. Moreover, Amira was able to increase at a compound annual growth rate of 15.5% between 2010 and 2017. With such high revenue growth rates, this company could be significantly undervalued by the market. According to Finviz, over 50% of the company is owned by insiders. That in mind, that shows that the company’s officers, directors, and key insiders are confident in the company. The Company has received numerous accolades: Since 2010, Amira has been recognized in multiple years by the World Economic Forum as a “Global Growth Company”, an invitation-only community consisting of ~300 of the world’s fastest-growing corporations The World Consulting & Research Corporation named Amira one of “Asia’s Most Promising Brands” Planman Marcom voted Amira the “INDIAN POWERBRAND” in the Food Category in 2011 and 2013 Amir was voted best partner in the “Staples” category in 2013 at the Bharti Walmart Private Limited Annual Supplier Conference VWP World Brand recognized the Amira Brand as “The Admired Brand of India” in 2014–2015 Inc. India featured Amira as one of India’s fastest growing mid-sized companies in 2010, 2011, 2012 and 2013 Product Portfolio Approximately three quarters of sales come from Basmati rice, the core focus of the company; Sells more than 20 owned brands globally, spanning numerous price points; Amira in India Amira has established 15 Company managed distribution centers in India to provide it greater control over its expansion efforts in its home country location. Amira is one of a handful of large relevant players in the domestic India market. Amira represents a meaningful opportunity to consolidate the market over time. Business Is Growing, Strategic Moves Will Expedite Growth Amira Foods is no startup. The international business is healthy and generated roughly $270 million in sales in 2018. Those numbers are coupled with respectable margins that rested at 14.3% of gross sales. However, the company expects to do better with the expectation to add an additional 100bp to the international margins. Notably, there will some be shrinkage to the margins, which may be adjusted lower to account for the separation of the Indian business, due to less vertical integration and less sourcing from the primary processor. However, even with the expected reductions in the margin and certain efficiencies, analysts are pointing to ANFI being able to maintain separate sales of roughly $200 million, albeit with a lower margin of approximately 650bp. However, even with the expected short-term declines, the assumption of the lesser $200 million in sales coupled with an EBITDA margin of an expected 8.8%, can imply that ANFI will generate a positive EBITDA run of roughly $17 million. And, that is a healthy number to build upon. Source: seekingalpha.com Recent Developments Appointment of Thomas Dennhardt (formerly Lidl) to CEO of Amira Basmati Rice GmbH (German subsidiary) Board appointment of Hervé Larren (formerly LVMH), bringing experience in building brands internationally EUR25mn Debt raise at 8.5% interest rate (due December 2023) Reduced ownership of India subsidiary to 49.8% Regains Compliance with NYSE Listing Requirements Latest News Amira Nature Foods Ltd Hires Brian M. Speck as Chief Financial Officer Amira Nature Foods Ltd (the "Company") (ANFI), a global provider of packaged specialty rice, today announced the hiring of Brian M. Speck as Chief Financial Officer. The Company continues to focus on the international growth of its brands and as such, continues to take steps to Westernize its corporate finance and executive team. Karan A. Chanana, Amira’s Chairman, commented, “Brian Speck is an excellent addition to our team, bringing his extensive financial and consumer industry background to the Company. We believe his many years of U.S. public company accounting experience will assist Amira in Westernizing our finance department as we focus on the international growth of our brands.” “I am excited to join the Company at a pivotal time in its history and helping it realize its international growth strategy,” Mr. Speck said. “After spending nearly two decades in various accounting roles, I look forward to bringing my experience to assist Amira’s efforts to grow its brands outside of India.” Since March 2018, Mr. Speck has been the Chief Financial Officer of Surge Holdings, Inc., a provider of a suite of financial and telecommunications services which are primarily marketed through small retail establishments which are utilized by members of its target market. Since October 2013, Mr. Speck has also been Director of Financial Reporting for Brio Financial Group, which the Company recently announced would be assisting the Company in its ongoing financial reporting. In his capacity at Brio, Mr. Speck consults various private and public companies in financial reporting, internal control development and evaluation, budgeting and forecasting. Prior to joining Brio, from 2011 to 2013, he was an audit supervisor at Wiss & Company. In that capacity, he was involved in the firm’s accounting and tax practice with industry focuses in manufacturing, wholesalers, construction contractors and professional service firms. Mr. Speck received a Master of Science in Accounting from Kean University. Market Outlook: Amira operates in the global packaged rice market and is a leading provider of Basmati rice, a long-grain aromatic rice with favorable health attributes that can be grown only in specific regions of the Indian sub-continent and part of the Punjab region located in Pakistan. The global rice market is an enormous market with stable growth, while specialty rice and specifically Basmati rice benefits from premium pricing and increasing consumption patterns. Demand for Basmati rice has remained strong over the past 10 years due to the increased consumption trends both in India and internationally. Leading players such as McCormick & Co., Hain Celestial, Rice 'n Spice, LT Foods, East End Foods, and Amira Nature Foods serve local as well as global consumers, which is reflected in the growth of Basmati rice market. The size of worldwide Basmati rice market was approximately $10.51 Billion in 2017 and is estimated to be worth $17.74 Billion by the end of 2022, with a robust CAGR of 11% between 2017 and 2022, according to Transparency Market Research (TMR). Rice is a $275bn Global Staple Category with Favorable Market Conditions Rice is the primary staple for >50% of the world’s population and provides > 20% of the global caloric intake Represents 30% of caloric consumption in Asia(4) Defensive and non-cyclical with steady growth Improves with age and has an extremely long shelf life (up to 5+ years) if stored properly Global rice consumption is growing, estimated to reach c.483 million metric tonnes in 2017(5) The global rice market is estimated at $275B and has grown at 2% volume CAGR over the 2010 – 2015 period Technical Analysis As we stated above, we've done our very own chart analysis and see the potential for a move of over +153% from here! We see a positive reversal from long-term support right here, and a positive cross looks imminent. The float of ANFI is extremely low for a NYSE listed company at just 25.82M. We know this ticker can make big moves on volume, so we wouldn't be too surprised if this ticker starts to breakout early. With its bullish $6.00 price target, we believe its upside potential far outweighs any downside risk. The Bottom Line ANFI has proven its ability run-up big in both the short and long-term. ANFI has the potential to be the biggest gainer on the NYSE, and deserves to be on the top of your watchlist. That being said, we ask that all members start their research on ANFI immediately, and consider building a position tomorrow morning at 9:30AM EST (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The PennyStock101 Team Don't Miss Our Next Huge Winner... Text 'PS101' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here within, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated fifteen thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI. We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources In LLC to conduct investor relations advertising and marketing for ANFI on three separate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
ALong
by RedHotStocks
Tesla has Strong Technicals to ReverseTesla is approaching strong support that has been present for multiple years. It is also massively oversold and if nothing else, due for a dead cat bounce to retest the downtrend. This looks to be a strong buy with low risk and great for long time investment. Happy Trading! Please donate if you like what I do! :) bitcoin: 1NTkRex1gE2iJ63sFQHNpFYkBoeZ3w69FZ bitcoin-cash: 1GYPijuWfRYtaWmFbPsFjWsozEP3ZXaheq ethereum: 0x56E49FB49221623C8FC7BE27C49E6d7Ff8d02c70 burstcoin: BURST-S9HQ-84BX-CXX8-4RKBC I haven't posted in a while but I am really looking into getting back into posting here so if you like what I do, a follow would make my day :)
NASDAQ:TSLALong
by stupendelious
1
GTEH belongs on the top of your watchlist. Only 1.2M in the floa======================== GTEH (GenTech Holdings Inc.) Alert Price: $0.0331 Float: 1.12M Chart Analysis Company Website | Recent News ======================== Members, Are ready to end this already highly profitable week of trading with a potential triple-digit gainer? Please turn your immediate attention to GTEH (GenTech Holdings Inc.). GTEH is in the process of creating a national chain of Hemp Centric Coffee Shop Retail Spaces where patrons can relax, drink CBD infused Teas and Coffees, try various own-brand products and experience holistic education and classes. The company is also building an extensive outreach program working with medical practitioners across the country in their own locations to educate their patients and increase awareness of the benefits of THC free CBD Products. All of this is offered under the brand 'The Healthy Leaf'. GTEH plans to enter the Apparel space and then, shortly after, the Consumer Goods sectors of the Hemp industry. Their intention is to continue to build a strong Board that can go into the growing market in the second half of the year with the acquisition of land ready for the growing of Hemp and producing CBD oils and products. Here's why GTEH needs to be the only ticker on your radar: Has one of the tightest floats we've ever seen. Has a well recorded history of monster single-session moves. Operates in a booming multi-billion dollar cannabis market. The Company is on a three-year trajectory that will see them launch new branding, make strategic acquisitions and deliver its own branded CBD oil throughout 2019 and into 2021. Recently announced the establishment of final lease negotiations for its first CBD coffee shop location. We believe that this highly volatile, low-float alert has the potential to run-up triple-digits tomorrow. In fact, we've done our very own chart analysis, and see the potential for a move of +282% from today's alert price! About GenTech Holdings, Inc. GenTech Holdings, Inc. is a publicly traded company under the symbol GTEH. The company is creating a national chain of Hemp Centric Coffee Shop Retail Spaces where patrons can relax, drink CBD infused Teas and Coffees, try various own-brand products and experience holistic education and classes. The company is also building an extensive outreach program working with medical practitioners across the country in their own locations to educate their patients and increase awareness of the benefits of THC free CBD Products. All of this is offered under the brand 'The Healthy Leaf'. GTEH recently announced its line of high-end CBD products set to be offered in the launch of its new "The Healthy Leaf" CBD brand over coming weeks. The initial products to be offered under "The Healthy Leaf" brand will include: High-End CBD-infused Box of Chocolates Premium CBD-infused Skin Cream CBD-infused Artisan Teas CBD-infused Artisan Coffees Premium CBD Wellness Snack Bar High-End CBD-infused Pet Treats 250ml Bottle of Premium CBD "We are laser-focused on differentiating ourselves from the herd as we launch The Healthy Leaf," commented David Lovatt, CEO of GenTech. "The health and wellness space is a culture. By focusing on a holistic lifestyle branding process, we are lining ourselves up with that culture, and with our target market. Everything flows from that idea." To assist with the launch, the Company has retained the services of Oxygen Graphics, a premier International Design Company. Oxygen will be tasked with logo design and the creation of the graphic representations that will define the brand, including business cards, kiosk and delivery truck insignias, product packaging design and graphics, labels, and web graphics. In addition, as part of the primary launch, the Company will be launching its new web presence in the form of a sophisticated customer-facing website, which will include an e-commerce engine preview and a 3D walk-thru model of its physical store design. The site should be live in two weeks. "This market is exploding with potential right now," continued Mr. Lovatt. "Growth estimates for the CBD market continue to ratchet higher. That matches what we are seeing from a boots-on-the-ground perspective as well. We have a very disruptive vision and we want to mobilize it as fast as possible. But the details need to be addressed with proper care. To that end, the Oxygen team brings professionalism, talent, and a wealth of experience to the table." Recent Developments for GTEH: GenTech Announces Official Launch in $2B CBD Market with First US Location Yesterday, GTEH announced the establishment of final lease negotiations for its first CBD coffee shop location, with a five-year lease now under review. The negotiation comes as part of an aggressive multi-week process during which the Company expects to confirm the towns chosen for its first three locations. “We have been all over the East Coast during the past couple weeks, working to nail down our initial locations,” noted David Lovatt, CEO of GenTech. “We first went to Miami, FL, in the trendy Wynwood area, then to Montclair, NJ, a wealthy suburban haven for professionals from New Jersey and New York. From there, we headed to SOHO and Williamsburg in New York – both extremely trendy, high-volume locations. The process has been highly productive, and we should have firm contractual commitments in place very soon, which will set in motion the most exciting steps of this strategy.” Management notes that the Company is now in a position to begin work on securing at least one location over the very near term, with several others likely to follow. The GenTech media team was also a part of the process, and the Company plans to release footage in the form of “video blogs” of the Company’s likely store locations to give shareholders a clear sense of the process in motion and the rare quality of the locations being considered as initial Healthy Leaf CBD Coffee Shop sites. “The Healthy Leaf pivot is moving at an extremely fast clip at this point,” continued Mr. Lovatt. “We are on the verge of nailing down our initial locations imminently, we expect to unveil our initial branding designs within the next week, the new website will be completed and unveiled within the next two weeks, and all of this will be transparently accessible to shareholders and the wider investment audience in real time as it unfolds.” Market Outlook According to "www.votehemp.com," the 2017 market for Hemp was buoyant with 13% of the $820m US market being made up of Consumer textiles, CBD making up 23% of that market and Food being 17%. They project that CBD oil derived products will exceed $646 million alone by 2022. The CBD market is one of the fastest growing consumer product markets on the planet right now, with some analysts projecting as much as 20x growth over the next 36 months. One of the truly unique facets to this growth curve is that has not been sponsored by any major existing brands from established large-cap corporate entities. It has been truly organic. Technical Analysis As we mentioned above, we may have never had an alert with a float this tight. Yahoo Finance has the float on GTEH listed at just 1.12M. We did the quick math, and that equates to just slight above $32K worth of shares available to the public for trading! With a float that tight, it's no wonder why GTEH has a proven history of monster single day moves. Here is just a small taste of the type of single-session gains GTEH is capable of delivering: 5/24 $0.0205 to $0.0339 for a gain of +65.37% 5/20 $0.0321 to $0.0440 for a gain of +37.07% 5/15 $$0.0340 to $0.0675 for a gain of +98.53% 4/30 $0.015 to $0.0270 for a gain of +80% We've done our very own chart analysis and see the potential for a move of over +282%! The Bottom Line If you are on the hunt for monster single-session gains, then GTEH is the only ticker that should be on your radar. That being said, we ask that you start your research on GTEH immediately and consider building a position tomorrow morning at 9:30AM EST (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by One 22 Media LLC to conduct investor relations advertising and marketing for GTEH. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. Unsubscribe This message was sent to jay.stockrockandroll@gmail.com from info@topmarketgainers.com Top Market Gainers MJ Capital, LLC | PennyStockLocks, LLC PO Box 110226 Nutley, NJ 07110
OTC:GTEHLong
by RedHotStocks
PARTY LIKE ITS 1999"Those Who Do Not Learn History Are Doomed To Repeat It." Qualcomm is mimicking the Chart Pattern it took during 1999-2000. QCOM just spiked over 45%, similar to the meteoric rise it experienced during the Dotcom bubble. The correction that Qualcomm is experiencing will reverse quickly after Chinese impose their retaliatory tariffs. (June 1st) So Before July 19th we should see another pulse upward in-between 5-15% that replicates the spike in 2000 after the initial price action. MACD, RSI, volatility and time cycles all play key factors here. After the pulse whether QCOM rises or falls depends on the trend of AAPL and the market.
NASDAQ:QCOM
by kingmidasLXIX
1
$TNXP looks ready to breakout big today. This low-float Nasdaq..TNXP looks ready to breakout big today. This low-float Nasdaq listed company could cure PSTD! ======================== TNXP (Tonix Pharmaceuticals Holding Corp.) Alert Price: $1.70 Float: 4.74M Chart Analysis Roth Capital Price Target: $4.00 Investor Presentation Company Website | Recent News ======================== Members, We ask that you give your full attention to our new low-float Nasdaq listed alert TNXP (Tonix Pharmaceuticals Holding Corp.). TNXP is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat psychiatric and pain conditions, and biological products to improve biodefense through potential medical counter-measures. Tonix’s lead program is for the development of Tonmya** (TNX-102 SL), which is in Phase 3 development as a bedtime treatment for PTSD. PTSD is a serious chronic psychiatric illness defined as a maladaptive prolonged stress response which occurs after experiencing severely injurious traumatic event(s). While initially recognized as a stress response to military combat ('shell shock') it is now known that many civilians exposed to life-threatening events, sexual assault, natural disasters or accidents, can develop PTSD. According to the latest report published by Credence Research, Inc. the global post-traumatic stress disorder therapeutics market is projected to reach US $10.679M by 2026, expanding at a CAGR of 4.5% from 2018 to 2026. TNXP Has the Potential to Be the Biggest Gainer On the Nasdaq With its low-float of 4.74M, TNXP is no stranger to massive single-day run-ups. Take a look at these past single-session gains: 3/14 $2.58 to $3.24 for gains of +25.58% 3/11 $2.80 to $4.12 for gains of +47.14% 3/8 $2.14 to $4.20 for gains of +96.26% 12/7 $3.15 to $7.24 for gains of +129.84% TNXP also has several bullish catalysts on the horizon: Chart has recently formed a "Golden Cross" which generally signals an uptrend. Roth Capital analyst Scott Henry upgraded TNXP from Neutral to Buy with a price target of $4.00. The Company will be presenting pharmacokinetic analyses of TNX-102 SL* in a poster at the American Society of Clinical Psychopharmacology (ASCP) 2019 Annual Meeting. Research has shown that PSTD treatment is not just for soldiers: Civilians with PTSD struggle to find effective therapy About Tonix Pharmaceuticals Holding Corp. Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat psychiatric and pain conditions, and biological products to improve biodefense through potential medical counter-measures. Tonix’s lead program is for the development of Tonmya** (TNX-102 SL), which is in Phase 3 development as a bedtime treatment for PTSD. Tonix is also developing TNX-102 SL as a bedtime treatment for fibromyalgia and agitation in Alzheimer’s disease under separate INDs to support potential pivotal efficacy studies. The fibromyalgia program is in Phase 3 development and the agitation in Alzheimer’s program is Phase 2 ready. The agitation in Alzheimer’s disease IND has been designated a Fast Track development program by the FDA. TNX-601 (tianeptine oxalate) is in the pre-IND application stage, also for the treatment of PTSD but by a different mechanism from TNX-102 SL and designed for daytime dosing. TNX-601 is also in development for a potential indication - neurocognitive dysfunction associated with corticosteroid use. A Phase 1 clinical formulation selection pharmacokinetic study of TNX-601 will be conducted outside of the U.S. in 2019. Tonix’s lead biologic candidate, TNX-801, is a potential smallpox-preventing vaccine based on a live synthetic version of horsepox virus, currently in the pre-IND application stage. * TNX-102 SL (cyclobenzaprine HCl sublingual tablets) is an investigational new drug and has not been approved for any indication. **Tonmya has been conditionally accepted by the U.S. Food and Drug Administration (FDA) as the proposed trade name for TNX-102 SL for the treatment of PTSD. This press release and further information about Tonix can be found at www.tonixpharma.com. Company Highlights: Phase 3 development of new bedtime treatment for PTSD, including military related PTSD Major unmet need; ~12 million Americans annually Benefited from FDA 505(b)(2) NDA approval requirement Complimentary day-time PTSD treatment in development Leverages development expertise in PTSD, i.e., regulatory, trial recruitment and execution Fibromyalgia bedtime treatment in development New Phase 3 study design features discussed with FDA (April 2019 FDA Meeting Minutes) TNX-102 SL 5.6 mg (twice the dose previously studied in FM Phase 2/3 trials) will be studied in Phase 3 to support the indication New indication in development for agitation in Alzheimer’s Disease Unmet medical need, no approved drug available Fast Track Phase 2/3 ready program Innovative vaccine in development to prevent Smallpox Opportunity to supply stockpiling requirement; short development path Studies in mice suggest improved safety profile Recently Completed Milestones July 2018 Completed P301/HONOR study interim analysis - result did not support study continuation but strengthened new Phase 3 study August 2018 Presentation of P301/HONOR study results at Military Health System Scientific Symposium October 2018 Met with FDA and received preliminary agreement on the design of new Phase 3 study of Tonmya for PTSD (P302/RECOVERY study) November 2018 Received FDA minutes confirming agreement on the design of P302/RECOVERY study March 2019 Met with FDA to discuss new FM Phase 3 study design using TNX-102 SL 5.6 mg March 2019 P302/RECOVERY study initiated April 2019 Received FDA formal minutes with clear guidance and support on new Phase 3 FM study Upcoming Milestones Second Half 2019 Preliminary human pharmacokinetic and safety data (non-IND study) from selected TNX-601 (tianeptine oxalate) formulation expected First Half 2020 Topline data from P302/RECOVERY study expected Market Outlook Globally, the vast majority of people (~70%) will experience or witness one or more life-threatening traumatic events in their life-time. For many, the response to an isolated traumatic event will dissipate over days or a few weeks and have little or no long-term consequences. For some individuals, however, the response to trauma will become chronic, lasting for more than one month and persisting for years, and, in many cases, decades. These individuals are considered to have PTSD and will experience psychiatric symptoms (flashbacks, intense anxiety and avoidance, emotional numbness, intense guilt or worry, agitation, sleep disturbances), and as a consequence, experience impaired social functioning, occupational disability, and an overall poor quality of life. PTSD is also characterized by overall high utilization of healthcare services, adding to the significant economic burden from the condition. How prevalent is PTSD? PTSD is a global problem, with the lifetime prevalence of PTSD estimated to be 3.9%, or affecting an estimated 200-300 million individuals, on a global basis. Based on U.S. 12-month prevalence rates,1,2 it is estimated that about 11.0 million American adults suffer from DSM-5-defined PTSD in a given year. Similar to other psychiatric disorders, only approximately half of these individuals will seek treatment at some point in the course of the disease, and of these, approximately 40% (~1.8 million) will be formally diagnosed with PTSD in any given year. Lack of awareness, the negative stigma associated with PTSD (like other mental disorders), as well as the limitations of existing treatment options, may be addressed by increased societal awareness and acceptance as well as the introduction of new therapeutic options. Technical Analysis As we stated above, with its low-float of 4.74M, TNXP is no stranger to massive single-day run-ups. TNXP's chart has recently formed a "Golden Cross" which generally signals an uptrend. We've done our very own chart analysis, and see the potential for a move of over +27%! The Bottom Line We are extremely bullish on TNXP. Based on our research we believe that this could be the biggest single-day gainer on the Nasdaq today. That being said, we ask that you start your research on TNXP immediately and consider building a position this morning at 9:30AM EST (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have NOTbeen compensated to conduct investor relations advertising and marketing for TNXP. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
NASDAQ:TNXPLong
by RedHotStocks
CMPY looking for a HUGE MOVE today! [Details Inside]===================== CMPY (Comepay Inc.) Alert Price: $1.57 Chart Analysis Float: 4.947M ======================== Members, Are you ready to end the week with a monster mover? If so, we ask that you turn your immediate attention to CMPY (Comepay Inc.). An Epic Bounce in the Making for this Low-Float Alert With it's tiny float of 4.947M, CMPY is extremely volatile, and has the potential to deliver gains of well over +100%! Take a look at some of these past monster moves that CMPY has made: On 4/22 shares jumped from $1.56 to a high of $3.14 the next day. Gain of 100%! On 4/30 shares jumped from $1.50 to a high of $2.00 the next day. Gain of 30%! Shares hit as low as $2.00 in March and then as high as $4.38 last month for a move of 119%! After a pullback of over 18% yesterday, shares of CMPY are now back at that attractive $1.50 range. Let's not forget that CMPY operates in a red hot FinTech sector, and has big name customers like Volvo, Asus, and Bosch. We also see several Bullish Catalysts for CMPY that could trigger a major reversal to its recent downtrend: An RSI of 38 (Very Close to Oversold Territory) Based on our very own chart analysis, we see the realistic potential for a +218% move. Plans to Uplist this Year Concluded an agreement with the National Payment Card System (“NSPK”) for the use of contactless payment system “Mir” for the Cassatka Mini series of smart terminals. Their wholly owned subsidiary Chek-Online LLC, a leading manufacturer of fiscal cash registers in Russia, and developer of the family of Cassatka smart terminals, has again added increased functionality to its smart terminals by integrating merchant acquiring services from two large banks in Russia for its versatile handheld Cassatka-Mini terminal. Chek-Online LLC, added increased functionality to its smart terminals including the Unified State Automated Information System (“USAIS”) app, in order to simplify reporting of alcoholic beverages and products to the Federal Tax Authority of the Russian Federation, including the ability to issue industry compliant receipts for alcoholic products sold. Added Asus as its newest customer in order to bring their online store compliant with Russian Federal Law 54, requiring businesses and individuals to use federally compliant cash registers, including a fiscal chip for processing sales transactions. Processes over 10 million customer payments per month and presently has more than 22,000 kiosks across Russia. Added increased functionality to its smart terminals including the Unified State Automated Information System (“USAIS”) app, in order to simplify reporting of alcoholic beverages and products to the Federal Tax Authority of the Russian Federation, including the ability to issue industry compliant receipts for alcoholic products sold. Upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Chek-online development staff are yet to disclose the name of the app and its exact release date, but expect the app to be launched no later than May of 2019. Recently signed up Volvo (Russia) for provision of stationary smart terminal units located inside its data centers in Russia. Entered into a lease agreement with Bosch, a global market leader in electronics and engineering, for provision of stationary smart terminal units located inside its data centers in Russia. Upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Partnership with Russian retail bank, Post Bank, for purchase and sale of the Cassatka, their fully compliant smart terminal cash register line to meet fiscal compliance legislation across Russia. We believe that this is the best time to take action for traders looking to catch CMPY's next profitable swing upwards. CMPY is trading just off its 52-week low, and has an RSI of 38 (Very Close to Oversold Territory). We see tons of upside potential from here, and anticipate a huge bounceback from CMPY today. We are asking all of our members to start their research on CMPY immediately, and consider building a position this morning at 9:30AM EST About Comepay Inc. (CMPY) The Comepay Inc. (CMPY) group of companies includes subsidiaries, Comepay, RP Systems, M-NN LLC and Chek-online, which have been operating for over 12 years providing instant payments and internet-based payment transactions via kiosks, mobile interfaces and web-based applications such as electronic wallets. CMPY also leases and sells cash registers and Point of Sale (POS) systems - compliant with the 54-FZ Law - including its recently developed proprietary multifunctional smart POS fiscal cash register system. CMPY processes over 4.7 million customer payments per month and now has more than 12,700 active kiosks across Russia! Among those who count themselves as customers of CMPY are auto-manufacturing giant, VOLVO-Russia, and ASUS - the World's #1 Gaming Computer brand. So it's no wonder this company has already seen Gross Revenues (unaudited) of over $9 MILLION in just the first 9 months of 2018! Needless to say, if any company is positioned to take advantage of Russia's new law -- it's CMPY. The Comepay group of companies including Comepay, RP Systems, M-NN LLC and Chek-online have been operating for over 11 years providing internet acquiring services and support, facilitating instant payments and internet-based payment transactions via kiosks, mobile interfaces and web-based applications such as electronic wallets. The Company also leases and sells cash registers and Point of Sale (POS) systems, including its recently developed proprietary multifunctional smart POS fiscal cash register system. Combining proprietary software and equipment, Comepay processes over 10 million customer payments per month and presently has more than 22,000 kiosks across Russia. The companies are currently focusing their planned business expansion on the smart POS fiscal cash register system called “Cassatka” in order to help businesses comply with newly released Russian taxation legislation, 54-FZ which requires 1.2 million businesses in fiscal 2018, and a further 1.4 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers. The Cassatka, Comepay’s multifunctional smart POS online fiscal cash register can process payments and meet fiscal data storage requirements for participating businesses. It is a convenient and cost competitive solution for businesses to meet the new federal taxation requirements in Russia, and is currently being manufactured for distribution prior to June 2018. As the companies expand their business model, we expect to offer blockchain acquiring services and also to accept payments in multiple crypto currencies on the Cassatka. The Comepay group of companies presently earn revenue from a variety of channels including fee based commissions on payment processing for both cash and debit card payments, software licensing, kiosk placement fees and other rental fees for cash registers and associated equipment. The Comepay companies are looking to expand rapidly in fiscal 2018 and beyond as we introduce and market the Cassatka along with a suite of enhanced user features. 5 Reasons Why We Think CMPY Needs to be on Top of Your Watchlist THE RIGHT SPACE How are tech stocks in the market looking? Wall Street will tell you it’s the hottest investment market in a decade. It’s on fire, literally and figuratively. INNOVATIVE PRODUCTS CMPY is all about the payments.CMPY uses tech to make payments easier and more efficient. We believe this provides investors a unique opportunity to acquire an interest in an upcoming tech company that could be a leader in the payment industry. UNDER THE RADAR Being new to the market and hovering under the radar of Wall Street, we believe CMPY is attractive in comparison to its peers. And up until now, one of the best-kept secrets. MASSIVE GROWTH POTENTIAL The market opportunity for CMPY is HUGE! Comepay could take the mobile payment markets by storm. THE BEST AND THE BRIGHTEST Boasting a “top-tier technology that is unmatched in the industry”, the CMPY provides a one-stop source for everything payment related. IS CMPY GOING TO REVOLUTIONIZE ONLINE PAYMENTS? Comepay, Inc. (CMPY) (“the Company”) is pleased to announce that its wholly owned subsidiary Chek-Online LLC, a leading manufacturer of fiscal cash registers in Russia, and developer of the family of Cassatka smart terminals has disclosed the upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Chek-online development staff are yet to disclose the name of the app and its exact release date, but expect the app to be launched no later than May of 2019. The mobile app is designed to allow all users who have downloaded the platform to easily find outlets that use the Cassatka online cash terminal: view all available products, compare prices, receive discounts and immediately place orders for delivery to any location in the city, paying remotely using their bankcard. The seller, in turn, will receive a notification about the online order on their Cassatka smart terminal, and will be able to process the order for delivery. The details of the products featured on the app will be made available using the built-in accounting system provided with the fiscal cash register. Business owners can update their back end system in order for the app to provide details such as products for sale, number of units in stock, price and available discounts. All information provided in the app is automatically synchronized with the individual login account for the business owner and transferred to the app. Data transferred to the app is available for download by any interested consumer. Currently, more than 20,000 individual businesses across Russia are selling their products and processing payments using our series of Cassatka online cash registers, with new users being added on a daily basis. According to the Chek-online development team, this app is intended to establish a direct connection between the seller and the buyer, creating a comfortable environment for online. The app is also intended to drive potential customers to mobile storefronts and encourage online trade. It was important to the Chek-online development team that users can compare both like products from storefronts in the same product category, as well as other product categories. As a result, potential customers are able to create a multi-category basket in the app pulling product from different stores into one easy to use comparison and purchase process. The app is designed to provide all the advantages and benefits that come with other online shopping providers. Customers will easily be able to access the necessary information about the products in order to quickly and efficiently be able to make an informed decision about online purchases. Recent Developments: Comepay, Inc. Subsidiary, Chek-online, Concludes Agreement with National Payment Card System (NSPK) on the Introduction of the Mir Contactless Payments System for Cassatka Mini VAUGHAN, ONTARIO, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Comepay, Inc. (OTC PINK: CMPY) (“the Company”) is pleased to announce that Chek-online LLC, a subsidiary of Comepay, Inc. and the manufacturer of the smart terminal and fiscal cash register line “Cassatka” has concluded an agreement with the National Payment Card System (“NSPK”) for the use of contactless payment system “Mir” for the Cassatka Mini series of smart terminals. NSPK, the operator of the Russian national contactless payment system “Mir” recently concluded an agreement with Chek-online for the supply of materials required to develop customized solutions for the Cassatka Mini mobile smart terminal, including contactless payments. The Cassatka Mini, designed as a handheld, easily transportable unit to help individuals and businesses comply with Russian Tax legislation 54-FZ is ideally suited for public transport, couriers, taxis and other similar businesses due to the built-in merchant acquiring, the ability to replenish travel card balances and make instant payments for transport, delivered goods and ticket purchases. The Cassatka Mini is currently processing payments made via the Visa and Mastercard payment systems. Implementation of the “Mir” contactless payment process shall consist of two stages: (i) technical protocol coordination and (2) full testing of the payment certification process. Once both testing stages are complete, the Cassatka Mini smart terminal will be officially included on the list of supported NSPK card payment devices. Mr. Dmitry Tsatskhin, CEO of Comepay, added, “Almost all the cards currently being issued in Russia are contactless. However, not all POS-terminals and online payment terminals can accept payments via contactless Mir card swiping. The certification underway for the contactless swiping system integrated with our Cassatka Mini will enable Mir Card holders to make any type of single-swipe purchases at any Cassatka Mini point of sale, further widening the appeal of our highly functional and compact hand held units.” Market Outlook: With all the political posturing about Russia, it's easy to forget that this country is growing significantly on it's way back to Superpower status. Russia's growth rate accelerated from 1.6 percent in 2017 and exceeded the economy ministry's prediction of 1.8 percent as well as the International Monetary Fund's forecast of 1.7 percent. Whether you agree with Putin or not, one thing is for sure -- he gets things done. For better or worse, the Russian press hardly ever questions the decisions the government makes or its political leaders like they do in the US. And when a law is put into place… everyone must follow. One such obscure new Russian law is called “54-FZ” - which REQUIRES millions of Russian businesses to install new federally compliant online cash registers. Needless to say, if any company is positioned to take advantage of Russia's new law -- it's CMPY. Global payments revenues swelled to $1.9 trillion in 2017, the best single year of growth in the last five years. This return to strong growth is being fueled primarily by sustainable volume increases, rather than less sustainable improvements in revenue margins, for both liquidity revenues (net interest income on liquid assets and deposits2 ) and transactional revenues (fee and float income on payments transactions). Indeed, margin improvement will barely contribute to the $410 billion increase in liquidity revenues between 2013 and 2018. Transactional revenues will increase by $340 billion by 2018 due to higher transaction volumes, despite the dampening effects of more regulation and competition. Technical Analysis: As we mentioned above, with it's tiny float of 4.947M CMPY is extremely volatile, and has the potential to deliver gains well over +100%. On 4/22 shares jumped from $1.56 to a high of $3.14 the next day. Gain of 100%. On 4/30 shares jumped from $1.50 to a high of $2.00 the next day. Gain of 30%. Shares hit as low as $2.00 in March and then as high as $4.38 last month for a move of 119%. After a pullback of over 18% yesterday, shares of CMPY are now back at that attractive $1.50 range. We believe that this is the best time to take action for traders looking to catch the next profitable swing upwards. CMPY is trading just off its 52-week low, and has an RSI of 38 (Very Close to Oversold Territory). Based on our very own chart analysis, we see the realistic potential for a +218% move. A run back to its 52-week high from today's alert price would result in gains of up to 234%! We see tons of upside potential from here, and anticipate a huge bounceback from CMPY today. Start your research on CMPY immediately, and consider building a position this morning at 9:30AM EST (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The TopMarketGainers Team Don't Miss Our Next Huge Winner... Text 'GAINS' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by ACN LLC to conduct investor relations advertising and marketing for CMPY. We have previously been compensated ten thousand dollars by ACN LLC to conduct investor relations advertising and marketing for CMPY on two seperate occasions which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
OTC:CMPYLong
by RedHotStocks
forexTrdr AUDCAD LOOKING INTERESTING AT SUPPORTAfternoon traders, Looking at Aussie dollar versus Canadian dollar as it trades around support levels from early March whilst matching up with extreme oversold levels on both RSI and stochastics. Additionally the move lower appears to be running out stream here both on volume and on price action with the pair sticking in a 30pip range for the past 24 hours. Our trading view chart should explain our view perhaps better than our description here. We are very mindful of the risk of Trump hitting twitter again with further hard ball talk around China and so we are positioning our lot sizes accordingly. As always we try to keep our analysis clean and easy for anyone to be able to follow but should you want to learn more then please do get in touch. Follow us on tradingview under forexTrdr to get our sample ideas free and immediately - its free to setup a profile and the charting tools and software is easier to use than Metatrader and most broker platforms. Good luck trading from the Team at forexTrdr find us on instagram, twitter and Alexa flash briefings
Long
by forexTrdr